Group One Trading
VYGR icon

Group One Trading’s Voyager Therapeutics VYGR Stock Holding History

Group One Trading’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.32K Buy
+600
New +$2.36K ﹤0.01% 7011
2025
Q3 		– Sell
-500
Closed -$1.55K – 9246
2025
Q2 		$1.55K Buy
+500
New +$1.61K ﹤0.01% 7477
2025
Q1 		– Sell
-13,600
Closed -$77.1K – 8445
2024
Q4 		$77.1K Buy
13,600
+10,600
+353% +$68.3K ﹤0.01% 4724
2024
Q3 		$17.6K Sell
3,000
-2,100
-41% -$15.3K ﹤0.01% 5297
2024
Q2 		$40.3K Buy
5,100
+100
+2% +$838 ﹤0.01% 4683
2024
Q1 		$46.5K Buy
5,000
+4,400
+733% +$37.1K ﹤0.01% 4777
2023
Q4 		$5.06K Sell
600
-4,000
-87% -$29K ﹤0.01% 6501
2023
Q3 		$35.6K Sell
4,600
-29,100
-86% -$266K ﹤0.01% 5404
2023
Q2 		$386K Sell
33,700
-116,600
-78% -$1.21M ﹤0.01% 3281
2023
Q1 		$1.16M Buy
+150,300
New +$1.2M ﹤0.01% 2009
2022
Q4 		– Sell
-1,600
Closed -$9K – 8172
2022
Q3 		$9K Sell
1,600
-7,900
-83% -$50.6K ﹤0.01% 6580
2022
Q2 		$56K Sell
9,500
-1,700
-15% -$11.5K ﹤0.01% 5462
2022
Q1 		$85K Buy
+11,200
New +$50K ﹤0.01% 5653
2021
Q4 		– Sell
-300
Closed -$1K – 8910
2021
Q3 		$1K Hold
300
– – ﹤0.01% 8049
2021
Q2 		$1K Sell
300
-600
-67% -$2.72K ﹤0.01% 8037
2021
Q1 		$4K Buy
+900
New +$6.14K ﹤0.01% 7304
2019
Q2 		– Sell
-400
Closed -$8K – 5434
2019
Q1 		$8K Buy
+400
New +$5.21K ﹤0.01% 4346
2018
Q2 		– Sell
-5,400
Closed -$101K – 5520
2018
Q1 		$101K Buy
5,400
+200
+4% +$4.32K ﹤0.01% 3236
2017
Q4 		$86K Buy
5,200
+4,200
+420% +$72K ﹤0.01% 3440
2017
Q3 		$21K Sell
1,000
-4,000
-80% -$45.1K ﹤0.01% 4051
2017
Q2 		$45K Buy
+5,000
New +$50.3K ﹤0.01% 3559

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Group One Trading's VYGR Position: Q1 2026 in Review

Group One Trading reduced its Voyager Therapeutics (VYGR) stake by 71% in Q1 2026, selling an estimated $5.76K and leaving 610 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #7003.

Group One Trading first reported a position in VYGR in Q2 2017 and has held it in 14 quarters since. The position peaked at $199K in Q3 2017. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Group One Trading held 610 shares of Voyager Therapeutics worth $2.35K as of Q1 2026.
  • Group One Trading sold 1,464 Voyager Therapeutics shares in Q1 2026, an estimated $5.76K.
  • Voyager Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7003 holding.
  • Group One Trading first reported a position in Voyager Therapeutics in Q2 2017 and has held it in 14 quarters since.
  • Group One Trading's Voyager Therapeutics position peaked at $199K in Q3 2017.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.